These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 4133419)

  • 21. Effects of mithramycin on Paget's disease of bone.
    Ryan WG; Schwartz TB; Perlia CP
    Trans Assoc Am Physicians; 1969; 82():353-62. PubMed ID: 5375158
    [No Abstract]   [Full Text] [Related]  

  • 22. Prediction and assessment of the response of Paget's disease to bisphosphonate treatment.
    Hosking DJ
    Bone; 1999 May; 24(5 Suppl):69S-71S. PubMed ID: 10321933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zoledronate in the treatment of Paget's disease.
    Siris E
    Br J Clin Pract Suppl; 1996 Sep; 87():19-20; discussion 22. PubMed ID: 8995014
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-hormonal drug treatment in Paget's disease].
    Ryckewaert A; Lemaire V; Tubiana M
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG; Birge SJ; Avioli LV
    N Engl J Med; 1970 Sep; 283(11):549-55. PubMed ID: 5450609
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
    [No Abstract]   [Full Text] [Related]  

  • 28. The treatment of Paget's bone disease with sodium ethidronate.
    Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
    Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of risedronate in Paget's disease.
    Miller PD
    Bone; 1999 May; 24(5 Suppl):91S-92S. PubMed ID: 10321937
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
    Frijlink WB; Bijvoet OL; te Velde J; Heynen G
    Lancet; 1979 Apr; 1(8120):799-803. PubMed ID: 86042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mithramycin on Paget's disease of bone.
    Ryan WG; Schwartz TB; Perlia CP
    Ann Intern Med; 1969 Mar; 70(3):549-57. PubMed ID: 5775034
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
    Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U
    Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
    O'Donoghue DJ; Hosking DJ
    Bone; 1987; 8(4):219-25. PubMed ID: 3128315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate.
    Khairi MR; Johnston CC; Altman RD; Wellman HN; Serafini AN; Sankey RR
    JAMA; 1974 Oct; 230(4):562-7. PubMed ID: 4213513
    [No Abstract]   [Full Text] [Related]  

  • 35. Paget's disease and bisphosphonates.
    Rendina D; De Filippo G; Mossetti G
    N Engl J Med; 2005 Dec; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract]   [Full Text] [Related]  

  • 37. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
    Smith ML; Fogelman I; Ralston S; Boyce BF; Boyle IT
    Metab Bone Dis Relat Res; 1984; 5(4):167-70. PubMed ID: 6429474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
    Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic success in Paget disease.
    Vaisrub S
    JAMA; 1973 Jun; 224(10):1413. PubMed ID: 4634178
    [No Abstract]   [Full Text] [Related]  

  • 40. Histological measurements in Paget's disease of bone.
    Walton RJ; Woods CG; Russell RG; Kanis JA; Clark MB
    Calcif Tissue Res; 1977 May; 22 Suppl():295-7. PubMed ID: 912533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.